Bavarian Nordic (Germany)

Recent papers from Bavarian Nordic (Germany)

1. Alternative approaches to phase III clinical trials for vaccine efficacy and licensure: the role of real-world evidence – a meeting reportBiologicals · 2026
2. Prognostic Value of [ ¹⁸ F]Flotufolastat PET Using Visual RECIP in Docetaxel-Treated Metastatic Prostate CancerJournal of Nuclear Medicine · 2026
3. An Ad26‐ MVA ‐ BN ‐based therapeutic vaccine targeting HPV16 and HPV18 related disease is immunogenic in preclinical models and in women with persistent HPV infectionsClinical & Translational Immunology · 2026
4. A chikungunya virus-like particle vaccine reduces chikungunya disease in cynomolgus macaques and protection is mediated by antibody transferred from vaccinated humansnpj Vaccines · 2026
5. Passive transfer of human sera from chikungunya virus virus-like particle vaccine (Vimkunya) recipients fully protects non-human primates from viremianpj Vaccines · 2026
6. To platform or not to platform: Strategic considerations for antibody formulation in early clinical developmentJournal of Pharmaceutical Sciences · 2025
7. High-quality phenotypic and genotypic dataset of barley genebank core collection to unlock untapped genetic diversityGigaScience · 2025
8. Chikungunya Virus VLP Vaccine: Phase 3 Trial in Adolescents and Adults2024
9. Equivalence of freeze-dried and liquid-frozen formulations of MVA-BN as smallpox and mpox vaccineHuman Vaccines & Immunotherapeutics · 2024
10. A phase 2 study of a brachyury‐targeting vaccine in combination with radiation therapy for the treatment of advanced chordomaCancer · 2024
11. Assessing myBaits Target Capture Sequencing Methodology Using Short-Read Sequencing for Variant Detection in Oat Genomics and BreedingGenes · 2024
12. MVA-based vaccines are protective against lethal eastern equine encephalitis virus aerosol challenge in cynomolgus macaquesnpj Vaccines · 2024
13. Intraperitoneal administration of a modified vaccinia virus Ankara confers single-chain interleukin-12 expression to the omentum and achieves immune-mediated efficacy against peritoneal carcinomatosisJournal for ImmunoTherapy of Cancer · 2023
14. Persistence of immunological memory as a potential correlate of long-term, vaccine-induced protection against Ebola virus disease in humansFrontiers in Immunology · 2023
15. Reduced Respiratory Syncytial Virus Load, Symptoms, and Infections: A Human Challenge Trial of MVA-BN-RSV VaccineThe Journal of Infectious Diseases · 2023
16. Preclinical development of a first-in-class vaccine encoding HER2, Brachyury and CD40L for antibody enhanced tumor eradicationScientific Reports · 2023
17. In-depth virological and immunological characterization of HIV-1 cure after CCR5Δ32/Δ32 allogeneic hematopoietic stem cell transplantationNature Medicine · 2023
18. The Quest for a Respiratory Syncytial Virus Vaccine for Older Adults: Thinking beyond the F ProteinVaccines · 2023
19. Comparison of PD-L1 expression in squamous cell cancer of unknown primary and oropharyngeal squamous cell carcinomaEuropean Archives of Oto-Rhino-Laryngology · 2022
20. Decreased Viral Load, Symptom Reduction, and Prevention of Respiratory Syncytial Virus Infection with MVA-BN-RSV Vaccine2022